مروری سیستماتیک بر ترند مصرف آنتی بیوتیک در دوران پساکرونا در ایران
کد: G-1111
نویسندگان: فرنگیس رجبی ℗, مبینا حسین فخرآبادی ©, ایمان معصومی, متین حسین فخرآبادی
زمان بندی: زمان بندی نشده!
دانلود: دانلود پوستر
خلاصه مقاله:
خلاصه مقاله
Introduction: The COVID-19 pandemic has had profound effects on health behaviors and medication consumption, including antibiotics, worldwide, particularly in Iran. This systematic review aims to investigate the trends in antibiotic consumption following the COVID-19 era in Iran. Methods: This systematic review involved searching for scientific articles in reputable databases, including PubMed, Scopus, Google Scholar, and SID. Articles published from 2020 to 2023 that addressed antibiotic use in Iran after the pandemic were selected. Keywords such as "antibiotic," "COVID," "microbial resistance," and "Iran" were utilized for the search. Inclusion criteria encompassed cross-sectional studies, clinical reports, and case studies focusing on antibiotic consumption and its changes post-COVID-19. Findings: Out of the reviewed articles, 25 met the inclusion criteria. Results indicated that in the early post-COVID period, antibiotic consumption increased due to concerns about secondary infections. However, over time, and with the implementation of prescribing control policies, this trend declined. Additionally, microbial resistance resulting from excessive use was identified as a significant challenge. This drug resistance was most notable against beta-lactam antibiotics (including penicillin and cephalosporins), quinolones (ciprofloxacin), carbapenems (including imipenem and meropenem), and macrolides (including azithromycin). Conclusion: The trend of antibiotic consumption in Iran after the COVID-19 pandemic reflects an initial increase followed by a gradual decrease. Nevertheless, microbial resistance remains a serious challenge that requires continuous monitoring and stringent policies regarding antibiotic prescribing.
کلمات کلیدی
Antibiotics, COVID-19, Microbial Resistance, Iran.
